Marshall Wace North America’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-272,991
| Closed | -$4.9M | – | 2000 |
|
|
2018
Q4 | $4.9M | Buy |
272,991
+224,331
| +461% | +$4.03M | 0.05% | 250 |
|
|
2018
Q3 | $1.43M | Buy |
+48,660
| New | +$1.43M | 0.01% | 548 |
|
|
2018
Q1 | – | Sell |
-477,557
| Closed | -$32.5M | – | 1779 |
|
|
2017
Q4 | $32.5M | Buy |
477,557
+112,137
| +31% | +$7.63M | 0.18% | 133 |
|
|
2017
Q3 | $30M | Buy |
365,420
+243,466
| +200% | +$20M | 0.19% | 145 |
|
|
2017
Q2 | $11.5M | Buy |
121,954
+25,862
| +27% | +$2.43M | 0.08% | 288 |
|
|
2017
Q1 | $6.15M | Buy |
+96,092
| New | +$6.15M | 0.05% | 352 |
|